Search by Drug Name or NDC
NDC 65862-0702-60 Ziprasidone Hydrochloride 20 mg/1 Details
Ziprasidone Hydrochloride 20 mg/1
Ziprasidone Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is ZIPRASIDONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Ziprasidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). It is also used to treat episodes of mania (frenzied, abnormally excited or irritated mood) or mixed episodes (symptoms of mania and depression that happen together) in patients with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Ziprasidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Related Packages: 65862-0702-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ziprasidone
Product Information
| NDC | 65862-0702 |
|---|---|
| Product ID | 65862-702_5f5b84de-9675-4d87-81dd-f22e7d257d0f |
| Associated GPIs | 59400085100120 |
| GCN Sequence Number | 047563 |
| GCN Sequence Number Description | ziprasidone HCl CAPSULE 20 MG ORAL |
| HIC3 | H7T |
| HIC3 Description | ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST |
| GCN | 13331 |
| HICL Sequence Number | 021974 |
| HICL Sequence Number Description | ZIPRASIDONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Ziprasidone Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ziprasidone Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | ZIPRASIDONE HYDROCHLORIDE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Atypical Antipsychotic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204117 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65862-0702-60 (65862070260)
| NDC Package Code | 65862-702-60 |
|---|---|
| Billing NDC | 65862070260 |
| Package | 60 CAPSULE in 1 BOTTLE (65862-702-60) |
| Marketing Start Date | 2016-12-27 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.27024 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ZIPRASIDONE HCL 20 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |